Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Omae

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Annals of Surgical Oncology|January 29, 2024
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" ScoreYudai Ishiyama, Kenji Omae, Tsunenori Kondo, et al.
Clinical Kidney Journal|September 8, 2020
The effect of transportation modality to dialysis facilities on health-related quality of life among hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Pattern StudyMasahiko Yazawa, Kenji Omae, Yugo Shibagaki, et al.
Japanese Journal of Clinical Oncology|January 23, 2022
Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre studyArisa Wada, Kenji Omae, Kazuhiko Yoshida, et al.
Psychiatry and Clinical Neurosciences|May 20, 2026
Public acceptance and expectations for Lecanemab: Insights from a Smallest Worthwhile Difference studyAran Tajika, Kenji Omae, Ethan Sahker, et al.
Urologic Oncology|May 14, 2017
Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2013
Mannitol has no impact on renal function after open partial nephrectomy in solitary kidneysKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Clinical Genitourinary Cancer|April 2, 2017
Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted TherapyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 17, 2023
Albumin-Bilirubin Score at Post-Hepatectomy Hepatocellular Carcinoma Recurrence: Impact on Survival and Association with Post-Hepatectomy Liver FailureHiroshi Horie, Satoshi Ogiso, Tomoaki Yoh, et al.
Targeted Oncology|March 30, 2016
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib TreatmentHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Japanese Journal of Clinical Oncology|March 11, 2016
The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinomaHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Annals of Surgical Oncology|January 29, 2024
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" ScoreYudai Ishiyama, Kenji Omae, Tsunenori Kondo, et al.
Clinical Kidney Journal|September 8, 2020
The effect of transportation modality to dialysis facilities on health-related quality of life among hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Pattern StudyMasahiko Yazawa, Kenji Omae, Yugo Shibagaki, et al.
Japanese Journal of Clinical Oncology|January 23, 2022
Comparison of surgical outcomes after robot-assisted laparoscopic partial nephrectomy between patients continuing and discontinuing aspirin therapy: a Japanese single-centre studyArisa Wada, Kenji Omae, Kazuhiko Yoshida, et al.
Psychiatry and Clinical Neurosciences|May 20, 2026
Public acceptance and expectations for Lecanemab: Insights from a Smallest Worthwhile Difference studyAran Tajika, Kenji Omae, Ethan Sahker, et al.
Urologic Oncology|May 14, 2017
Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2013
Mannitol has no impact on renal function after open partial nephrectomy in solitary kidneysKenji Omae, Tsunenori Kondo, Toshio Takagi, et al.
Clinical Genitourinary Cancer|April 2, 2017
Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted TherapyHiroki Ishihara, Tsunenori Kondo, Kazuhiko Yoshida, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 17, 2023
Albumin-Bilirubin Score at Post-Hepatectomy Hepatocellular Carcinoma Recurrence: Impact on Survival and Association with Post-Hepatectomy Liver FailureHiroshi Horie, Satoshi Ogiso, Tomoaki Yoh, et al.
Targeted Oncology|March 30, 2016
Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib TreatmentHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Japanese Journal of Clinical Oncology|March 11, 2016
The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinomaHiroki Ishihara, Tsunenori Kondo, Kenji Omae, et al.
Pageof 11